Utah Medical Products, Inc. (UTMD)
NASDAQ: UTMD · IEX Real-Time Price · USD
69.91
-1.09 (-1.54%)
At close: Jul 19, 2024, 4:00 PM
69.94
+0.03 (0.04%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Utah Medical Products Revenue

Utah Medical Products had revenue of $49.04M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $11.34M. In the year 2023, Utah Medical Products had annual revenue of $50.22M.

Revenue (ttm)
$49.04M
Revenue Growth
-6.54%
P/S Ratio
5.03
Revenue / Employee
$258,126
Employees
190
Market Cap
246.67M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202350.22M-2.06M-3.93%
Dec 31, 202252.28M3.23M6.58%
Dec 31, 202149.05M6.88M16.30%
Dec 31, 202042.18M-4.73M-10.08%
Dec 31, 201946.90M4.91M11.68%
Dec 31, 201842.00M584.00K1.41%
Dec 31, 201741.41M2.12M5.38%
Dec 31, 201639.30M-859.00K-2.14%
Dec 31, 201540.16M-1.12M-2.72%
Dec 31, 201441.28M785.00K1.94%
Dec 31, 201340.49M-1.06M-2.55%
Dec 31, 201241.55M3.69M9.75%
Dec 31, 201137.86M12.74M50.71%
Dec 31, 201025.12M-795.00K-3.07%
Dec 31, 200925.92M-1.87M-6.72%
Dec 31, 200827.78M-720.00K-2.53%
Dec 31, 200728.50M-251.00K-0.87%
Dec 31, 200628.75M1.06M3.83%
Dec 31, 200527.69M1.21M4.56%
Dec 31, 200426.49M-652.00K-2.40%
Dec 31, 200327.14M-224.00K-0.82%
Dec 31, 200227.36M407.00K1.51%
Dec 31, 200126.95M-239.00K-0.88%
Dec 31, 200027.19M-2.25M-7.65%
Dec 31, 199929.44M1.77M6.38%
Dec 31, 199827.68M3.41M14.03%
Dec 31, 199724.27M-14.40M-37.24%
Dec 31, 199638.67M-3.37M-8.00%
Dec 31, 199542.04M--
Dec 31, 1994---
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AVITA Medical 51.50M
Mersana Therapeutics 38.30M
Senseonics Holdings 23.30M
Profound Medical 5.33M
Immutep 4.58M
Cibus 2.32M
Atai Life Sciences 277.00K
Sera Prognostics 206.00K
Revenue Rankings